Nonselective IKr-Blockers Do not Induce Torsades de Pointes in the Anesthetized Rabbit During α1-Adrenoceptor Stimulation
- 1 December 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 36 (6) , 728-736
- https://doi.org/10.1097/00005344-200012000-00007
Abstract
Selective I(Kr)- (the rapid component of the delayed rectifier potassium current) blockers are known to induce torsades de pointes (TdPs) in anesthetized rabbits during alpha1-adrenoreceptor stimulation. However, effects of nonselective I(Kr)-blockers, which produce TdPs in other animal models and in humans, are not known in this model. We examined two nonselective I(Kr)-blockers (quinidine, 1.25 mg/kg/min i.v [n = 7]; and terfenadine, 0.31 mg/kg/min i.v. [n = 7]) for their effects on electrocardiographic parameters and on incidence of cardiac arrhythmias in anesthetized rabbits during alpha1-adrenoceptor stimulation with methoxamine. We compared the drugs with two highly selective I(Kr)-blockers (dofetilide, 0.04 mg/kg/min i.v. [n = 7]; and clofilium, 0.08 mg/kg/min i.v. [n = 6]). Polymorphic ventricular tachycardia or TdPs were induced by dofetilide and clofilium at mean doses > or =0.33 mg/kg and 0.4 mg/kg i.v., in all animals tested (vs. none in solvent; p < 0.05). TdPs usually developed into ventricular fibrillation and developed after prolongation of QT/JT interval and of QT dispersion. Terfenadine and quinidine significantly increased PQ, QT, and QTc interval and largely increased QRS duration and QT dispersion. These compounds elicited intraventricular conduction defects and cardiac arrest, due to asystole, in all animals tested (vs. 0% in solvent; p < 0.05). Interestingly, these two nonselective I(Kr)-blockers did not produce TdPs or ventricular fibrillation in any animals tested. Our results thus indicate that selective I(Kr)-blockers elicit TdPs, whereas nonselective I(Kr)-blockers do not induce this type of arrhythmia in this rabbit model. Consequently, it should be noted that this rabbit model is not always useful to evaluate nonselective I(Kr)-blocker-induced TdPs and QT interval and QT dispersion, rather than TdPs, are also important indicators for drug-induced cardiac arrhythmias.Keywords
This publication has 32 references indexed in Scilit:
- Proarrhythmia of Azimilide and Other Class III Antiarrhythmic Agents in the Adrenergically Stimulated RabbitProceedings of the Society for Experimental Biology and Medicine, 2000
- Effects of adenosine A1-receptor activation on torsade de pointes in rabbits.Cardiovascular Drugs and Therapy, 1999
- Dynamics of QT dispersion during myocardial infarction and ischaemiaInternational Journal of Cardiology, 1996
- Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome.Circulation, 1994
- Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisationsCardiovascular Research, 1993
- QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the RabbitJournal of Cardiovascular Pharmacology, 1990
- QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.Heart, 1990
- The long QT syndromes: A critical review, new clinical observations and a unifying hypothesisProgress in Cardiovascular Diseases, 1988
- Torsades de pointes associated with drugs and toxins: Recognition and managementAmerican Heart Journal, 1987
- Spatial variation of QT intervals in normal persons and patients with acute myocardial infarctionJournal of the American College of Cardiology, 1985